168 related articles for article (PubMed ID: 16965641)
1. Breast cancer risk associated with different HRT formulations: a register-based case-control study.
Dinger JC; Heinemann LA; Möhner S; Thai do M; Assmann A
BMC Womens Health; 2006 Sep; 6():13. PubMed ID: 16965641
[TBL] [Abstract][Full Text] [Related]
2. Colon cancer risk and different HRT formulations: a case-control study.
Dinger JC; Heinemann LA; Möhner S; Thai do M; Assmann A
BMC Cancer; 2007 May; 7():76. PubMed ID: 17488513
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.
Sit AS; Modugno F; Weissfeld JL; Berga SL; Ness RB
Gynecol Oncol; 2002 Aug; 86(2):118-23. PubMed ID: 12144815
[TBL] [Abstract][Full Text] [Related]
4. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
5. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
[TBL] [Abstract][Full Text] [Related]
8. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
9. Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women.
de Lignières B; de Vathaire F; Fournier S; Urbinelli R; Allaert F; Le MG; Kuttenn F
Climacteric; 2002 Dec; 5(4):332-40. PubMed ID: 12626212
[TBL] [Abstract][Full Text] [Related]
10. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
11. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in women receiving estrogen-progestin replacement therapy.
Persson I
Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk factors in Turkey: a hospital-based case-control study.
Sezer H; Yilmaz M; Gurler H; Koyuncu A
Asian Pac J Cancer Prev; 2011; 12(9):2317-22. PubMed ID: 22296377
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
17. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies.
Yu X; Zhou S; Wang J; Zhang Q; Hou J; Zhu L; He Y; Zhao J; Zhong S
Breast Cancer; 2017 Sep; 24(5):643-657. PubMed ID: 28601917
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
20. Risk of venous thromboembolism in users of hormone replacement therapy.
Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
